Literature DB >> 14747992

Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va.

Andrew J Gale1, John H Griffin.   

Abstract

Activation of the anticoagulant human plasma serine protease zymogen, protein C, by a complex of thrombin and the membrane protein, thrombomodulin, generates activated protein C, a physiologic anti-thrombotic, anti-inflammatory and anti-apoptotic agent. Alanine-scanning site-directed mutagenesis of residues in five surface loops of an extensive basic surface on protein C was used to identify residues that play essential roles in its activation by the thrombin-thrombomodulin complex. Twenty-three residues in the protein C protease domain were mutated to alanine, singly, in pairs or in triple mutation combinations, and mutants were characterized for their effectiveness as substrates of the thrombin-thrombomodulin complex. Three protein C residues, K192, R229, and R230, in two loops, were identified that provided major contributions to interactions with thrombin-thrombomodulin, while six residues, S190, K191, K217, K218, W231, and R312, in four loops, appeared to provide minor contributions. These protein C residues delineated a positively charged area on the molecule's surface that largely overlapped the previously characterized factor Va binding site on activated protein C. Thus, the extensive basic surface of protein C and activated protein C provides distinctly different, though significantly overlapping, binding sites for recognition by thrombin-thrombomodulin and factor Va. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747992     DOI: 10.1002/prot.10627

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  8 in total

Review 1.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

2.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

3.  Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosis.

Authors:  Abdulrahman Alsultan; Andrew J Gale; Kadijah Kurban; Mohammed Khalifah; Fahad B Albadr; John H Griffin
Journal:  Thromb Res       Date:  2016-04-23       Impact factor: 3.944

4.  Down-regulation of the clotting cascade by the protein C pathway.

Authors:  Fabian Stavenuiter; Eveline A M Bouwens; Laurent O Mosnier
Journal:  Hematol Educ       Date:  2013

Review 5.  Exosites in the substrate specificity of blood coagulation reactions.

Authors:  P E Bock; P Panizzi; I M A Verhamme
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

6.  Role of the activation peptide in the mechanism of protein C activation.

Authors:  Bosko M Stojanovski; Leslie A Pelc; Enrico Di Cera
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

7.  Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.

Authors:  Laith Altaweel; Daniel Sweeney; Xizhong Cui; Amisha Barochia; Charles Natanson; Peter Q Eichacker
Journal:  Biologics       Date:  2009-09-15

8.  Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia.

Authors:  Xiao-Yan Zhao; Andreas Wilmen; Dongli Wang; Xinquan Wang; Maxine Bauzon; Ji-Yun Kim; Lars Linden; Liang Li; Ursula Egner; Tobias Marquardt; Dieter Moosmayer; Jan Tebbe; Julian Marius Glück; Philipp Ellinger; Kirk McLean; Shujun Yuan; Subramanian Yegneswaran; Xiaoqiao Jiang; Vince Evans; Jian-Ming Gu; Doug Schneider; Ying Zhu; Yifan Xu; Cornell Mallari; Ashley Hesslein; Yan Wang; Nicole Schmidt; Katrin Gutberlet; Christine Ruehl-Fehlert; Alexius Freyberger; Terry Hermiston; Chandra Patel; Derek Sim; Laurent O Mosnier; Volker Laux
Journal:  Nat Commun       Date:  2020-06-12       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.